On Friday, Shares of Zimmer Biomet Holdings (NYSE: ZBH) lost -0.43% to $115.92. The stock grabbed the investor’s attention and traded 1,250,400 shares as compared to its average daily volume of 1.21M shares. The stock’s institutional ownership stands at 91.90%.
Zimmer Biomet Holdings Inc. (ZBH) stated a fourth-quarter loss of $901.10M, after reporting a profit in the same period a year earlier. On a per-share basis, the Warsaw, Indiana-based company said it had a loss of $4.42. Earnings, adjusted for asset impairment costs and non-recurring costs, were $2.18 per share. The results met Wall Street expectations. The average estimate of 14 analysts surveyed by Zacks Investment Research was also for earnings of $2.18 per share.
The orthopedic device maker posted revenue of $2.070B in the period, beating Street forecasts. Twelve analysts surveyed by Zacks expected $2.060B.
For the year, the company stated a loss of $379.20M, or $1.86 per share, swinging to a loss in the period. Revenue was stated as $7.930B. It anticipates full-year earnings in the range of $7.70 to $7.90 per share.
ZBH has a market value of $24.08B while its EPS was booked as $-1.49 in the last 12 months. The stock has 207.72M shares outstanding. In the profitability analysis, the company has gross profit margin of 72.10% while net profit margin was -3.90%. Beta value of the company was 1.20; beta is used to measure riskiness of the security. Analyst recommendation for this stock stands at 2.30.
Robert Thomas has over 14 years experience in the investments on the institutional side of markets and has an “insider” view on the markets. In addition, he is an futures day trader that focuses on analyzing fundamentals, specifically earnings reports and technical levels. He has a Masters Degree in Business and Economics.